Calidi Biotherapeutics Correlations

CLDI Stock

0.59 0.03 4.84%

The current 90-days correlation between Calidi Biotherapeutics and Fossil Group is 0.13 (i.e., Average diversification). The correlation of Calidi Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Calidi Biotherapeutics Correlation With Market

Average diversification

The correlation between Calidi Biotherapeutics and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Calidi Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Calidi Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Calidi Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Calidi Stock please use our How to Invest in Calidi Biotherapeutics guide.

Moving against Calidi Stock

0.31	BCH	Banco De Chile	Pair Corr
0.44	T	ATT Inc Earnings Call This Week	Pair Corr
0.37	TRV	The Travelers Companies	Pair Corr
0.36	WMT	Walmart Sell-off Trend	Pair Corr

Related Correlations Analysis

	FOSL	CAH	TITN	CDW	SNCY	ZEUS	GMS
FOSL		0.81	0.86	0.84	0.88	0.48	0.62	FOSL
CAH	0.81		0.75	0.68	0.75	0.45	0.72	CAH
TITN	0.86	0.75		0.92	0.85	0.47	0.49	TITN
CDW	0.84	0.68	0.92		0.86	0.35	0.36	CDW
SNCY	0.88	0.75	0.85	0.86		0.63	0.61	SNCY
ZEUS	0.48	0.45	0.47	0.35	0.63		0.68	ZEUS
GMS	0.62	0.72	0.49	0.36	0.61	0.68		GMS
	FOSL	CAH	TITN	CDW	SNCY	ZEUS	GMS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Calidi Stock performing well and Calidi Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Calidi Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
FOSL	3.71	0.62	0.20	0.44	3.27	(4.84)	8.81	(5.15)	27.12
CAH	0.91	0.20	0.09	0.61	1.03	(0.94)	2.39	(1.84)	7.05
TITN	2.08	0.09	0.06	0.19	1.89	(2.40)	4.70	(3.11)	13.23
CDW	1.35	0.10	0.10	0.21	1.13	(1.65)	2.72	(2.48)	10.41
SNCY	2.65	0.10	0.10	0.17	2.85	(3.35)	7.16	(4.80)	17.65
ZEUS	1.78	(0.04)	0.02	0.11	2.16	(1.85)	3.98	(3.40)	14.85
GMS	2.00	0.54	0.35	0.65	0.93	(2.39)	4.56	(2.61)	25.00

Calidi Biotherapeutics Corporate Management

Andrew Jackson	Chief Officer	Profile
PharmD Santidrian	Head Officer	Profile
Stephen Thesing	Chief Officer	Profile
Thomas Herrmann	Managing Development	Profile
Wendy Esq	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC